{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "Thr",
          "alt": "Arg",
          "position": "240"
        },
        "variant_string_id": "PARK2 T240R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Autosomal recessive juvenile parkinsonism (AR–JP) is characterized by selective dopaminergic neural cell death and the absence of the Lewy body, a cytoplasmic inclusion body consisting of aggregates of abnormally accumulated proteins. The function of the gene product, parkin, remains unknown.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the selective neural cell death in AR-JP associated with the absence of Lewy bodies."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper reports that parkin is involved in protein degradation as a ubiquitin-protein ligase collaborating with the ubiquitin-conjugating enzyme UbcH7, and that mutant parkins from AR–JP patients show loss of the ubiquitin-protein ligase activity.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant is enzyme activity assay, which effectively models the disease pathogenesis/mechanism defined in Step 1, as it directly assesses the function of parkin as a ubiquitin-protein ligase, which is central to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls and replicates, as well as the use of domain-structure analysis to determine the region that contributes to the interaction with UbcH7. It also examines the effect of missense mutations on this interaction."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "judgment": "Yes",
          "reasoning": "The paper specifically examines the parkinT240R variant and reports that it did not associate with UbcH7, indicating a loss of function, which is directly relevant to the disease mechanism of AR-JP."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The parkinT240R variant was shown to lose the ability to bind UbcH7, which is essential for the ubiquitin-protein ligase activity of parkin. Given that this activity is central to the disease mechanism of AR-JP, the functional evidence strongly supports a pathogenic role for this variant."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "Arg",
          "alt": "Pro",
          "position": "42"
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Autosomal recessive juvenile parkinsonism (AR–JP) is characterized by selective dopaminergic neural cell death and the absence of the Lewy body, a cytoplasmic inclusion body consisting of aggregates of abnormally accumulated proteins. The function of the gene product, parkin, remains unknown.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the selective neural cell death in AR-JP associated with the absence of Lewy bodies."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper reports that parkin is involved in protein degradation as a ubiquitin-protein ligase collaborating with the ubiquitin-conjugating enzyme UbcH7, and that mutant parkins from AR–JP patients show loss of the ubiquitin-protein ligase activity.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant is enzyme activity assay, which effectively models the disease pathogenesis/mechanism defined in Step 1, as it directly assesses the function of parkin as a ubiquitin-protein ligase, which is central to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls and replicates, as well as the use of domain-structure analysis to determine the region that contributes to the interaction with UbcH7. It also examines the effect of missense mutations on this interaction."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "judgment": "Yes",
          "reasoning": "The paper specifically examines the parkinR42P variant and reports that it was capable of binding UbcH7 but failed to co-immunoprecipitate ubiquitinated proteins, indicating a loss of function in the ubiquitin-protein ligase activity of parkin, which is directly relevant to the disease mechanism of AR-JP."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The parkinR42P variant was shown to be capable of binding UbcH7 but failed to co-immunoprecipitate ubiquitinated proteins, indicating a loss of function in the ubiquitin-protein ligase activity of parkin. Given that this activity is central to the disease mechanism of AR-JP, the functional evidence strongly supports a pathogenic role for this variant."
    }
  ]
}